Literature DB >> 712390

Treatment of moyamoya disease with STA-MCA anastomosis.

J Karasawa, H Kikuchi, S Furuse, J Kawamura, T Sakaki.   

Abstract

Moyamoya disease is a chronic occlusive cerebrovascular disease of unknown etiology for which no effective treatment has been found. The authors report the result of 23 superficial temporal-middle cerebral artery (STA-MCA) anastomoses and seven encephalomyosynangioses, performed on 13 cases with moyamoya disease and on four additional atypical cases. There were 10 children and seven adults in this study. The follow-up period ranged from 1 year and 4 months to 4 years and 1 month postoperatively; nine patients had excellent results, five good, and one fair; two patients were unchanged. The anastomotic procedure was most effective for transient ischemic attacks, reversible ischemic neurological deficits, and even minor or moderate neurological symptoms. The STA-MCA anastomosis appears to be an effective treatment for moyamoya disease.

Entities:  

Mesh:

Year:  1978        PMID: 712390     DOI: 10.3171/jns.1978.49.5.0679

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  44 in total

1.  Acute Preoperative Infarcts and Poor Cerebrovascular Reserve Are Independent Risk Factors for Severe Ischemic Complications following Direct Extracranial-Intracranial Bypass for Moyamoya Disease.

Authors:  Michael U Antonucci; Terrence C Burns; T Michael Pulling; Jarrett Rosenberg; Michael P Marks; Gary K Steinberg; Greg Zaharchuk
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

2.  Reoperation for moyamoya disease refractory to encephalo-duro-arterio-synangiosis.

Authors:  T Matsushima; S Fujiwara; S Nagata; K Fujii; M Fukui; K Hasuo
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 3.  Moyamoya disease in pregnancy: a case series and review of management options.

Authors:  Jacklyn C Ma; Janet M Burlingame
Journal:  Hawaii Med J       Date:  2011-08

4.  Treatment course and outcomes after revascularization surgery for moyamoya disease in adults.

Authors:  Amanda Kahn; Gurmeen Kaur; Laura Stein; Stanley Tuhrim; Mandip S Dhamoon
Journal:  J Neurol       Date:  2018-09-08       Impact factor: 4.849

5.  Intradural arteriosynangiosis in pediatric moyamoya disease: modified technique of encephalo-duro-arterio-synangiosis with reduced operative damage to already growing revascularization.

Authors:  Jun Muto; Shizuo Oi
Journal:  Childs Nerv Syst       Date:  2009-03-18       Impact factor: 1.475

6.  Chronic low-perfusion state in children with moyamoya disease following revascularization.

Authors:  H Sato; N Sato; N Tamaki; S Matsumoto
Journal:  Childs Nerv Syst       Date:  1990-05       Impact factor: 1.475

Review 7.  Cerebrovascular Moyamoya disease.

Authors:  Y Yamashiro; H Takahashi; K Takahashi
Journal:  Eur J Pediatr       Date:  1984-04       Impact factor: 3.183

8.  Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism.

Authors:  Won-Hyung Kim; Sang-Dae Kim; Myung-Hyun Nam; Jin-Man Jung; Sung-Won Jin; Sung-Kon Ha; Dong-Jun Lim; Hae-Bin Lee
Journal:  Childs Nerv Syst       Date:  2018-10-03       Impact factor: 1.475

9.  Childhood moyamoya disease before and after encephalo-duro-arterio-synangiosis: an angiographic study.

Authors:  I Yamada; Y Matsushima; S Suzuki
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

10.  Intraoperative infrared brain surface blood flow monitoring during superficial temporal artery-middle cerebral artery anastomosis in patients with childhood moyamoya disease.

Authors:  Atsuhiro Nakagawa; Miki Fujimura; Tatsuhiko Arafune; Ichiro Sakuma; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2008-07-12       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.